Company Encyclopedia
View More
name
Hualan Vac
301207.SZ
Hualan Biological Vaccine Inc. engages in the research and development, production, and sale of vaccines and genetic engineering biological products in China. The company offers influenza vaccine (split virion), recombinant hepatitis B vaccine (hansenula polymorpha), meningococcal polysaccharide vaccine, influenza vaccine (split virion) quadrivalent, and meningococcal polysaccharide vaccine. It also sells self-produced products.
1.585 T
301207.SZMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
BiotechnologyIndustry
Industry Ranking33/81
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE1.20%D
    • Profit Margin7.22%B
    • Gross Margin75.49%A
  • Growth ScoreE
    • Revenue YoY-40.80%E
    • Net Profit YoY-85.84%E
    • Total Assets YoY-6.05%D
    • Net Assets YoY-6.88%D
  • Cash ScoreD
    • Cash Flow Margin1385.72%B
    • OCF YoY-40.80%E
  • Operating ScoreE
    • Turnover0.13E
  • Debt ScoreA
    • Gearing Ratio20.96%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Afternoon flu concept shows partial fluctuations, Hualan Vac rises over 10%

    In the afternoon, there was a partial fluctuation in the anti-influenza concept, with Hualan Vac rising over 10%. Zhifei Biological, Teva Pharmaceutical, Jinshi Yayao, and Hendi Pharmaceutical quickly surged

    Zhitong·
    SZ
    002007
    +0.32%
    SZ
    301207
    -1.09%
    Zhitong·
    SZ
    002007
    +0.32%
    SZ
    301207
    -1.09%

    Hualan Vac released its performance for the first three quarters, with a net profit attributable to the parent company of 132 million yuan, a decrease of 50.51%

    Hualan Vac released its Q3 2025 report, with operating revenue for the first three quarters at 806 million yuan, a year-on-year decrease of 15.81%; net profit attributable to the parent company was 132 million yuan, a year-on-year decline of 50.51%; net profit excluding non-recurring gains and losses was 86.2557 million yuan, a year-on-year decrease of 56.02%; basic earnings per share were 0.2224 yuan

    Zhitong·
    SZ
    301207
    -1.09%
    Zhitong·
    SZ
    301207
    -1.09%

    Overview of A-share dividends and stock distributions: 9 stocks have their equity registration today

    According to Wind data, today 9 A-shares are undergoing equity registration, all of which plan to distribute dividends, with the registration date set for October 24th. Among them, Hualan Vac, HUALAN BIOLOGICAL, and Xizhuang Co., Ltd. have the highest dividend payouts, at 6.00 yuan, 5.00 yuan, and 3.00 yuan per 10 shares, respectively. In addition, 12 stocks have announced dividend plans, with Wireless Media, Baolidi, and Songzhi Co., Ltd. having the highest dividend payouts, at 3.75 yuan, 2.0 yuan, and 1.5 yuan per 10 shares, respectively

    Zhitong·
    SZ
    002007
    +0.32%
    SZ
    301207
    -1.09%
    Zhitong·
    SZ
    002007
    +0.32%
    SZ
    301207
    -1.09%

    Overview of the lifting of restrictions on the circulation of A-shares | August 18

    On August 18, 19 listed companies had their restricted shares unlocked, with a total market value of approximately 32.581 billion yuan. The unlocking situation includes: TYN (000591) additional issuance of 314 million shares for original A-share shareholders, PasiLing (600215) equity incentive restricted circulation of 2.0375 million shares, ENN-NG (600803) additional issuance of 253 million shares for legal persons, and Hualan Vac (301207) extension of the restricted lock-up period for 459 million shares, etc

    Zhitong·
    SZ
    301207
    -1.09%
    SZ
    000591
    +0.67%
    SH
    600803
    -1.01%
    Zhitong·
    SZ
    301207
    -1.09%
    SZ
    000591
    +0.67%
    SH
    600803
    -1.01%

    Overview of A-share lock-up stock release: Lock-up stocks worth 46.718 billion yuan are released today

    On Monday, 17 companies had their restricted shares unlocked, with a total of 2.626 billion shares released and a market value of 46.718 billion yuan. GCORE, Hualan Vac, and Solar had the highest unlock volumes, at 1.05 billion shares, 459 million shares, and 314 million shares, respectively. In terms of market value unlocked, GCORE, Hualan Vac, and Kema Technology were 16.391 billion yuan, 8.528 billion yuan, and 4.88 billion yuan, respectively. Six companies had an unlock ratio exceeding 10%, with Hualan Vac, Zhongchu Media, and GCORE having unlock ratios of 76.37%, 47.33%, and 40.38%, respectively

    Zhitong·
    SH
    688728
    +1.99%
    SZ
    301207
    -1.09%
    Zhitong·
    SH
    688728
    +1.99%
    SZ
    301207
    -1.09%
    © 2025 Longbridge｜Disclaimer